a<p>Data presented as mean ± standard deviation for 3 independent studies performed in duplicate;</p>b<p>Data presented for a single experiment preformed in duplicate;</p>c<p>Data previously reported <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0087548#pone.0087548-Ray1" target="_blank">[35]</a>. Ambrisentan, bosentan, and macitentan were tested in concentrations ranging from 0.14–100 µM.</p><p>ND = not determined.</p
Fexofenadine (FEX), an H1-receptor antagonist, is eliminated from the liver mainly in an unchanged f...
Abstract: Tolvaptan is a selective V 2 -receptor antagonist primarily metabolized by CYP3A. The pres...
ABSTRACT: Data on treatment of patients with portopulmonary hypertension (PoPH) are limited, as they...
Inhibition of the transporter-mediated hepatobiliary elimination of bile salts is a putative mechani...
Treatment of pulmonary arterial hypertension with the endo-thelin receptor antagonist bosentan has b...
<p>Bosentan and macitentan treatment resulted in a dose-dependent reduction in total accumulation of...
<p>ERAs were evaluated either in the absence or presence of the transporter inhibitors rifampicin (4...
<p>(A) HepaRG cells were treated with 1 µM of <sup>3</sup>H-TC for 300 sec at 4, 24 and 96 h after s...
<p>Ambrisentan displayed the lowest intracellular accumulation followed by bosentan, sitaxsentan, an...
ImpacellInternational audienceSeveral endothelin receptor antagonists (ERAs) have been developed for...
In non-alcoholic steatohepatitis (NASH), decreased nitric oxide and increased endothelin-1 (ET-1, al...
Some endothelin receptor antagonists (ERAs) are associated with liver function test (LFT) result abn...
With efforts to reduce cytochrome P450-mediated clearance (CL) during the early stages of drug disco...
Intrahepatic cholestasis represents a frequent manifestation of drug-induced liver injuries; however...
<p>Human PASMCs were pre-incubated with dilution series of antagonists for 120 min followed by the a...
Fexofenadine (FEX), an H1-receptor antagonist, is eliminated from the liver mainly in an unchanged f...
Abstract: Tolvaptan is a selective V 2 -receptor antagonist primarily metabolized by CYP3A. The pres...
ABSTRACT: Data on treatment of patients with portopulmonary hypertension (PoPH) are limited, as they...
Inhibition of the transporter-mediated hepatobiliary elimination of bile salts is a putative mechani...
Treatment of pulmonary arterial hypertension with the endo-thelin receptor antagonist bosentan has b...
<p>Bosentan and macitentan treatment resulted in a dose-dependent reduction in total accumulation of...
<p>ERAs were evaluated either in the absence or presence of the transporter inhibitors rifampicin (4...
<p>(A) HepaRG cells were treated with 1 µM of <sup>3</sup>H-TC for 300 sec at 4, 24 and 96 h after s...
<p>Ambrisentan displayed the lowest intracellular accumulation followed by bosentan, sitaxsentan, an...
ImpacellInternational audienceSeveral endothelin receptor antagonists (ERAs) have been developed for...
In non-alcoholic steatohepatitis (NASH), decreased nitric oxide and increased endothelin-1 (ET-1, al...
Some endothelin receptor antagonists (ERAs) are associated with liver function test (LFT) result abn...
With efforts to reduce cytochrome P450-mediated clearance (CL) during the early stages of drug disco...
Intrahepatic cholestasis represents a frequent manifestation of drug-induced liver injuries; however...
<p>Human PASMCs were pre-incubated with dilution series of antagonists for 120 min followed by the a...
Fexofenadine (FEX), an H1-receptor antagonist, is eliminated from the liver mainly in an unchanged f...
Abstract: Tolvaptan is a selective V 2 -receptor antagonist primarily metabolized by CYP3A. The pres...
ABSTRACT: Data on treatment of patients with portopulmonary hypertension (PoPH) are limited, as they...